Perforated jejunal diverticulitis in the setting of biologic therapy presenting as transverse Colon diverticulitis : A case report

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved..

INTRODUCTION: Small bowel diverticula are a rare entity and are mostly found in the duodenum on diagnosis. Some common complications of this pathology include bleeding, obstruction, diverticulitis, and perforation. Furthermore, there is growing evidence supporting an association between biologic therapies and spontaneous intestinal perforation.

PRESENTATION OF CASE: We present a case of a 79-year-old female on prednisone, hydroxychloroquine, and tofacitinib for rheumatoid arthritis who was misdiagnosed with transverse colonic diverticulitis and eventually found to have perforated jejunal diverticulitis on laparotomy.

DISCUSSION: While tofacitinib has been associated with spontaneous intestinal perforation, it has not been documented as an aggravating factor in small bowel diverticular disease.

CONCLUSION: It is imperative to maintain a high index of suspicion for this pathology in immunosuppressed patients with an atypical presentation of diverticular disease.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:118

Enthalten in:

International journal of surgery case reports - 118(2024) vom: 12. Apr., Seite 109615

Sprache:

Englisch

Beteiligte Personen:

Dourado, Justin [VerfasserIn]
Jassir, Fauzi Feris [VerfasserIn]
Pavlovsky, Arthur [VerfasserIn]
Blumofe, Karin [VerfasserIn]

Links:

Volltext

Themen:

Biologic therapy
Case Reports
Case report
Immunosuppression
Misdiagnosis
Perforation
Small bowel diverticula

Anmerkungen:

Date Revised 26.04.2024

published: Print-Electronic

Citation Status Publisher

doi:

10.1016/j.ijscr.2024.109615

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM371047900